neurology Flashcards
features of generalised epilepsy
- Lack of aura
- Young age of onset
- Photosensitivity and myoclonus
- Seizures within 24hr of awakening
- History of alcohol or sleep deprivation
- Family history of IGS
features of focal epilepsy
focal aura automatisms - lip smacking, tongue biting, finger rolling post attack confusion nocturnal events history of perinatal injury
types of generalised seizures
absence - brief pause the carries on as normal
tonic clonic - LOC. limbs stiffen (tonic) then jerks (clonic)
myoclonic -sudden jerking of limb/face/truck
atonic - sudden loss of muscle tone causing fall, no LOC
types of focal seizures
simple - awareness unimpaired, no postictal symptoms
complex - awareness is impaired, aura
evolving to bilateral convulsive - starts focalliy but spreads and becomes convulsive (2/3 of all focal seizures)
treatment for epilepsy
focal - lamotrigine, levetiracetam, carbamazepine
generalised - valproate, lamotrigine, levetiracetam
define status epilepticus
repeated/prolonged seizure activity
defined as 2 or more seizures without full recovery in between or continuous activity for > 30 min
investigation of epilepsy
clinical history + eye witness ct head EEG glucose electrolytes
management of Status epilepticus
maintain airway
oxygen
IV access and bloods (FBC, U&Es, LFTs, glucose, Tox screen, anticonvulsant levels)
IV fluids
Lorazepam bolus (second dose if no response)
in seizures continue = IV phenytoin infusion
define MS
an inflammatory demyelinating disease characterised by the presence of episodic neurological dysfunction in at least 2 areas of the CNS separated in time and space
Risk factors of MS
genetics - HLA A3
Fhx
smoking
EBV infection
how might someone with MS present
optic neuritis transverse myelitis sensory changes (burning or wet sensation) leg weakness increased tone ataxia diplopia
define transverse myelitis
inflammation of the spinal cord most commonly in the thoracic (T1-12) region
features of transverse myelitis
weakness and sensory loss below the level affected
urinary incontinence
diagnosis of MS
MRI gadolinium brain
LP - CSF oligoclonal bands, raised IgG
rule out other causes (B12, lyme serology, TSH)
management of MS
IV methylprednisolone for relapses
Beta interferon to decrease frequency of relapses
biologics - natalizumab, alemtuzumab
fingolimod, dimethyl fumarate
symptom relief - muscle relaxants, anticholinergics
define myasthenia gravis
autoantibodies against ACh receptors causing destruction of post synaptic membrane therefore decreasing muscle fibre A.P
presentation of myasthenia gravis
muscle fatigue, worse with activity
limb weakness - difficulty standing up from chair, using stairs
ocular muscle weakness - squints and diplopia
dyspnoea
investigations for myasthenia gravis
ACh receptor antibodies
muscle specific tyrosine kinase antibodies
CT to look for thymoma
management of myasthenia gravis
cholinesterase inhibitor - pyridostigmine
corticosteroids for ocular symptoms
plasma exchange and IV IG
thymectomy
define a myasthenic crisis
development of respiratory failure due to weakness of respiratory muscles
what should be monitored in a myasthenic crisis
serial FVC and NIF
both low is an indication for ventilation
clinical features of TACS
hemiparesis + higher cortical dysfunction + homonymous hemianopia
clinical features of PACS
isolated higher cortical dysfunction
or
2 of hemiparesis, hemianopia, higher cortical dysfunction
clinical features of POCS
isolated hemianopia
cerebellar/brainstem symptoms (nystagmus, ataxia)
clinical features of LACS
pure motor stroke or pure sensory stroke or sensorimotor stroke or ataxic hemiparesis or clumsy hand dysarthria
vessel affected in TACS
proximal middle cerebral or internal carotid
vessel affected in PACS
MCA